Denmark has decided to exclude Johnson & Johnson’s COVID-19 product from its vaccination program following reports of rare blood clots in recipients. The European Union’s drug regulator last month said blood clots confirmed after inoculation with the Johnson & Johnson vaccine should be listed as a very rare side effect. It also said the benefit of the vaccine in preventing COVID-19 outweighs the risk. The Danish Health Authority said yesterday it independently examined the matter, and that it will halt the plan to use Johnson & Johnson vaccine.
- Nearly 200,000 A/Level candidates qualify to apply for universities
- Dambulla Dedicated Economic Centre will be reopened for trading from today under strict health guidelines.